These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9563801)
1. Decreased expression and release of dipeptidyl peptidase IV (CD26) in cultured peripheral blood T lymphocytes of oral cancer patients. Uematsu T; Urade M; Yamaoka M J Oral Pathol Med; 1998 Mar; 27(3):106-10. PubMed ID: 9563801 [TBL] [Abstract][Full Text] [Related]
2. Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients. Uematsu T; Urade M; Yamaoka M; Yoshioka W J Oral Pathol Med; 1996 Oct; 25(9):507-12. PubMed ID: 8959560 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes. Mattern T; Scholz W; Feller AC; Flad HD; Ulmer AJ Scand J Immunol; 1991 Jun; 33(6):737-48. PubMed ID: 1675482 [TBL] [Abstract][Full Text] [Related]
4. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain? Iwaki-Egawa S; Watanabe Y; Fujimoto Y Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235 [TBL] [Abstract][Full Text] [Related]
5. Influence of human T lymphocytes identified by antibodies to dipeptidyl peptidase IV on differentiation of human B lymphocytes stimulated with Staphylococcus aureus Cowan I and pokeweed mitogen. Gruber M; Scholz W; Flad HD Cell Immunol; 1988 May; 113(2):423-34. PubMed ID: 2896071 [TBL] [Abstract][Full Text] [Related]
6. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations. Ruiz P; Zacharievich N; Shenkin M Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992 [TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26. Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177 [TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders. Hildebrandt M; Rose M; Mayr C; Arck P; Schüler C; Reutter W; Salama A; Klapp BF Adv Exp Med Biol; 2000; 477():197-204. PubMed ID: 10849747 [TBL] [Abstract][Full Text] [Related]
9. Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Hildebrandt M; Rose M; Mayr C; Schüler C; Reutter W; Salama A; Klapp BF Scand J Immunol; 1999 Nov; 50(5):536-41. PubMed ID: 10564557 [TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity. Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727 [TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status. Ruiz P; Hao L; Zucker K; Zacharievich N; Viciana AL; Shenkin M; Miller J Transpl Immunol; 1997 Jun; 5(2):152-61. PubMed ID: 9269038 [TBL] [Abstract][Full Text] [Related]
12. Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro. Pinheiro MM; Stoppa CL; Valduga CJ; Okuyama CE; Gorjão R; Pereira RM; Diniz SN Eur J Pharm Sci; 2017 Mar; 100():17-24. PubMed ID: 28065853 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Korom S; De Meester I; Stadlbauer TH; Chandraker A; Schaub M; Sayegh MH; Belyaev A; Haemers A; Scharpé S; Kupiec-Weglinski JW Transplantation; 1997 May; 63(10):1495-500. PubMed ID: 9175816 [TBL] [Abstract][Full Text] [Related]
14. Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes. Varga T; Somogyi A; Barna G; Wichmann B; Nagy G; Rácz K; Selmeci L; Firneisz G Pathol Oncol Res; 2011 Dec; 17(4):925-30. PubMed ID: 21785903 [TBL] [Abstract][Full Text] [Related]
15. CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis. Cordero OJ; Varela-Calviño R; López-González T; Calviño-Sampedro C; Viñuela JE; Mouriño C; Hernández-Rodríguez Í; Rodríguez-López M; Aspe de la Iglesia B; Pego-Reigosa JM PLoS One; 2015; 10(7):e0131992. PubMed ID: 26177310 [TBL] [Abstract][Full Text] [Related]
16. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation. Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353 [TBL] [Abstract][Full Text] [Related]
17. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Ulmer AJ; Mattern T; Feller AC; Heymann E; Flad HD Scand J Immunol; 1990 Apr; 31(4):429-35. PubMed ID: 1970666 [TBL] [Abstract][Full Text] [Related]
18. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)). Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349 [TBL] [Abstract][Full Text] [Related]
19. Identification of the target of monoclonal antibody A6H as dipeptidyl peptidase IV/CD26 by LC MS\MS. Hass GM; Meyer JL; Newitt RA; Labuda T; Brown L; Aebersold R; Vessella RL Hybridoma; 2001 Aug; 20(4):231-6. PubMed ID: 11604108 [TBL] [Abstract][Full Text] [Related]
20. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells. Iwaki-Egawa S; Watanabe Y; Fujimoto Y Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]